ONCY
Oncolytics Biotech Inc.NASDAQHealthcare$0.96+3.25%ClosedMarket Cap: $96.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-33.35
P/S
0.00
EV/EBITDA
-4.46
DCF Value
$0.01
FCF Yield
-15.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1292.7%
ROA
-379.3%
ROIC
-1715.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-2.2M | $-1.5M | $-0.01 | — |
| FY 2025 | $0.00 | NaN% | $-28.7M | $-28.8M | $-0.30 | — |
| Q3 2025 | $0.00 | NaN% | $-13.8M | $-14.4M | $-0.14 | — |
| Q2 2025 | $0.00 | NaN% | $-5.7M | $-6.2M | $-0.07 | — |
| Q1 2025 | $0.00 | NaN% | $-7.0M | $-6.7M | $-0.08 | — |
| Q4 2024 | $0.00 | NaN% | $-8.4M | $-8.0M | $-0.10 | — |
| FY 2024 | $0.00 | NaN% | $-35.0M | $-31.7M | $-0.41 | — |
| Q3 2024 | $0.00 | NaN% | $-9.9M | $-9.5M | $-0.12 | — |
| Q2 2024 | $0.00 | -Infinity% | $-5.8M | $-5.3M | $-0.10 | — |
| Q1 2024 | $0.00 | -Infinity% | $-8.7M | $-6.9M | $-0.09 | — |
| Q4 2023 | $0.00 | -Infinity% | $-8.8M | $-3.9M | $-0.05 | — |
| FY 2023 | $0.00 | -Infinity% | $-25.0M | $-20.6M | $-0.41 | — |